Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Aug;30(8):2656-66.
doi: 10.1002/hbm.20692.

Corpus callosum damage and cognitive dysfunction in benign MS

Affiliations

Corpus callosum damage and cognitive dysfunction in benign MS

Sarlota Mesaros et al. Hum Brain Mapp. 2009 Aug.

Abstract

Corpus callosum (CC), the largest compact white matter fiber bundle of the human brain involved in interhemispheric transfer, is frequently damaged in the course of multiple sclerosis (MS). Cognitive impairment is one of the factors affecting quality of life of patients with benign MS (BMS). The aim of this study was to investigate the relationship between the cognitive profile of BMS patients and the extent of tissue damage in the CC. Brain conventional and DT MRI scans were acquired from 54 BMS patients and 21 healthy controls. Neuropsychological tests (NPT) exploring memory, attention, and frontal lobe cognitive domains were administered to the patients. DT tractography was used to calculate the mean diffusivity (MD) and fractional anisotropy (FA) of the CC normal appearing white matter (NAWM). An index of CC atrophy was also estimated. Nine (17%) BMS patients fulfilled criteria for cognitive impairment. Compared with controls, BMS had significantly different CC diffusivity and volumetry (P < 0.001). Compared with cognitively preserved patients, those with CI had significantly higher CC lesion volume (LV) (P = 0.02) and NAWM MD (P = 0.02). The scores obtained at PASAT were significantly correlated with CC T2 LV, and NAWM FA and MD (r values ranging from -0.31 to 0.66, P values ranging from 0.04 to <0.001). Cognitive impairment in BMS is associated with the extent of CC damage in terms of both focal lesions and diffuse fiber bundle injury. MRI assessment of topographical distribution of tissue damage may represent a rewarding strategy for understanding the subtle clinical deficits of patients with BMS.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Statistical parametric mapping analysis (color‐coded for t values) of corpus callosum regions with increased mean diffusivity (MD): A: Benign multiple sclerosis (BMS) patients vs. healthy controls; B: BMS patients with vs. without cognitive impairment (P < 0.05, corrected for multiple comparisons).
Figure 2
Figure 2
Statistical parametric mapping analysis of corpus callosum regions with decreased fractional anisotropy (FA) values in benign multiple sclerosis patients vs. healthy controls (P < 0.05, corrected for multiple comparisons). Clusters are shown in yellow over the FA atlas.
Figure 3
Figure 3
Statistical parametric mapping (SPM) analysis (color‐coded for t values) of corpus callosum regions with significant lower Jacobian determinants in benign multiple sclerosis patients vs. healthy controls. The splenium, bilaterally (A, B) and the right genu (B) were identified (P < 0.05, corrected for multiple comparisons).
Figure 4
Figure 4
T2 lesion probability maps (red) and areas with significantly increased mean diffusivity (blue) in cognitively‐impaired vs. cognitively‐preserved benign multiple sclerosis patients, overlaid on the fractional anisotropy atlas.
Figure 5
Figure 5
A: Statistical parametric mapping (SPM) regions where corpus callosum (CC) fractional anisotropy (FA) values were significantly correlated with the scores obtained at the paced auditory serial attention test (PASAT) (P < 0.05, corrected for multiple comparisons). B: SPM regions where CC mean diffusivity values were significantly correlated with PASAT (P < 0.05, corrected for multiple comparisons). Clusters are shown in yellow over the FA atlas.

References

    1. Amato MP,Portaccio E ( 2007): Clinical outcome measures in multiple sclerosis. J Neurol Sci 259: 118–122. - PubMed
    1. Amato MP,Ponziani G,Pracucci G,Bracco L,Siracusa G,Amaducci L ( 1995): Cognitive impairment in early‐onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4‐year follow‐up. Arch Neurol 52: 168–172. - PubMed
    1. Amato MP,Zipoli V,Goretti B,Portaccio E,De Caro MF,Ricciuti L,Siracusa G,Masini M,Sorbi S,Trojano M ( 2006): Benign multiple sclerosis: Cognitive, psychological and social aspects in a clinical cohort. J Neurol 253: 1054–1059. - PubMed
    1. Amato MP,Portaccio E,Stromilo ML,Goretti B,Zipoli V,Siracusa G,Battaglini M,Giorgio A,Bartolozzi ML,Guidi L,Sorbi S,Federico A,De Stefano N ( 2008): Cognitive assessment and quantitative magnetic resonance imaging can help to identify benign multiple sclerosis. Neurology 71: 632–638. - PubMed
    1. Arnett PA,Rao SM,Bernardin L,Grafman J,Yetkin FZ,Lobeck L ( 1994): Relationship between frontal lobe lesions and Wisconsin Card Sorting Test performance in patients with multiple sclerois. Neurology 44: 420–425. - PubMed

Publication types